• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Tal Medical launches study of MR-based depression device

Tal Medical launches study of MR-based depression device

September 9, 2015 By Fink Densford

Tal MedicalTal Medical said today it launched a dose optimization trial of its low field magnetic stimulation device designed to treat depression and other neuropsychiatric disorders.

The company said it enrolled the 1st patient in the randomized, placebo-controlled 120-patient study, with data from the trial expected in early 2017.

“Initiating the dose optimization study represents a significant milestone in our strategy to bring a safe, rapidly-acting treatment to patients suffering from major depressive disorder. We look forward to advancing this study and assessing various dosing regimens with the potential to provide significant medical benefits to depression patients,” CEO Jan Skvarka said in prepared remarks.

Tal Medical said the FDA cleared the trial as a nonsignificant risk study, which allows the company to proceed with the study without submitting and obtaining investigational device exemption.

The approval is granted to studies not considered to present a potential for serious risk to the health, safety or welfare of the subject, the company said.

The device uses non-invasive neuromodulation technology that has been shown in previous trials to have a rapid-acting effect on major depressive and bipolar depressive disorders, Tal Medical said.

In July, MassDevice.com spoke with Tal Medical CEO Skvarka about the company’s hopes of being 1 of the 1st medical device companies to explore a potential new vertical for medtech: Psychiatry.

Filed Under: Clinical Trials, Neurological, Neuromodulation/Neurostimulation Tagged With: Tal Medical

More recent news

  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Philips prices $1.1B offering to pay off debt, finance green projects
  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy